Clinical Insights and Strategies to Improve AML Care: Experts Provide Guidance on Personalizing Treatment in an Era of Rapidly Emerging Data and Clinical Complexity

Optimize your treatment of AML with expert perspectives and emerging practice-changing data.

Share

Program Content

Activities

New Strategies for AML
Improving Outcomes With New Therapies for Patients With Acute Myeloid Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 12, 2019

Expires: February 11, 2020

Using New Therapies in AML
Optimizing Treatment Decisions With New Therapies for Patients With Acute Myeloid Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 29, 2019

Expires: April 27, 2020

Activities

AML at ASH 2018
My Selections for Key AML Abstracts at ASH 2018
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2018

Expires: December 02, 2019

Integrating New AML Drugs
Integrating New AML Drugs Into a Rapidly Changing Treatment Paradigm
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2019

Expires: March 20, 2020

Faculty

cover img faculity

Jeffrey E. Lancet, MD

Senior Member & Professor
Chair,
 Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals, Inc.